FR518M - - Google Patents
Info
- Publication number
- FR518M FR518M FR837324A FR837324A FR518M FR 518 M FR518 M FR 518M FR 837324 A FR837324 A FR 837324A FR 837324 A FR837324 A FR 837324A FR 518 M FR518 M FR 518M
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
- C07D213/71—Sulfur atoms to which a second hetero atom is attached
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR837324A FR518M (sv) | 1960-08-31 | 1960-08-31 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR837324A FR518M (sv) | 1960-08-31 | 1960-08-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
FR518M true FR518M (sv) | 1961-05-15 |
Family
ID=88412541
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR837324A Active FR518M (sv) | 1960-08-31 | 1960-08-31 |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR518M (sv) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0131861A2 (en) * | 1983-07-06 | 1985-01-23 | Fabrica De Productos Quimicos Y Farmaceuticos Abello, S.A. | 2-Substituted-3-sulfonamidepyridine compounds, process for preparing and pharmaceutical compositions comprising the same |
-
1960
- 1960-08-31 FR FR837324A patent/FR518M/fr active Active
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0131861A2 (en) * | 1983-07-06 | 1985-01-23 | Fabrica De Productos Quimicos Y Farmaceuticos Abello, S.A. | 2-Substituted-3-sulfonamidepyridine compounds, process for preparing and pharmaceutical compositions comprising the same |
EP0131861A3 (en) * | 1983-07-06 | 1987-01-07 | Fabrica De Productos Quimicos Y Farmaceuticos Abello, S.A. | 2-substituted-3-sulfonamidepyridine compounds, process for preparing and pharmaceutical compositions comprising the same |